bioMérieux SA (BIM)
Euronext
Closed
Aug 25, 2026
Day's Range
74.3052 wk Range
65.60Overview - BIM - bioMérieux SA
Key Statistics
Valuation
Enterprise Value
8.53B
P/E (Trailing)
19.10
P/E (Forward)
15.97
Price / Sales (TTM)
2.19
Price / Book
2.04
EV / EBITDA
8.12
Profitability
Profit Margin
11.59%
Operating Margin
15.23%
Return on Assets
7.23%
Return on Equity
11.22%
Ownership
Shares Outstanding
117.98M
Float
40.02M
Held by Insiders
66.46%
Held by Institutions
16.76%
Price stats
Beta
0.57
50-Day Avg
70.97
200-Day Avg
87.81
Dividends
Payout Ratio
25.12%
Frequency
Annual
Market Cap - BIM - bioMérieux SA
Peers - BIM - bioMérieux SA
Peer Comparison
Compared with companies in Diagnostics & Research listed on Euronext.
- BIMEuronextbioMérieux SA8.76BMarket Cap-69.26%52-week change19.10P/E (Trailing)11.59%Profit Margin
- DIAEuronextSPDR Dow Jones Industrial Average ETF Trust34.10BMarket Cap+16.49%52-week change5.08P/E (Trailing)—Profit Margin
- ERFEuronextEurofins Scientific SE12.62BMarket Cap+8.90%52-week change25.29P/E (Trailing)7.17%Profit Margin
- LBIRDEuronextLumibird SA569.29MMarket Cap+31.39%52-week change40.70P/E (Trailing)6.13%Profit Margin
- ALECREuronextEurofins Cerep SAS82.21MMarket Cap-12.88%52-week change17.18P/E (Trailing)11.63%Profit Margin
- ALKLHEuronextKlea Holding Inc.47.13MMarket Cap-39.40%52-week change15.40P/E (Trailing)10.29%Profit Margin
- ALPREEuronextPredilife S.A.4.37MMarket Cap-193.69%52-week change-1.11P/E (Trailing)98.07%Profit Margin
Profile Summary - BIM - bioMérieux SA
About
bioMérieux SA is a family-owned French company and a world leader in the field of in vitro diagnostics, founded in 1963 by the Mérieux family. It pioneers, develops, and produces high-quality diagnostic solutions to improve public health worldwide, with a core purpose of making the world a healthier place through…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
